These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 35446403)

  • 1. Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing.
    Liu X; Xiong W; Qi Q; Zhang Y; Ji H; Cui S; An J; Sun X; Yin H; Tian T; Zhou X
    Nucleic Acids Res; 2022 May; 50(8):4769-4783. PubMed ID: 35446403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
    Peng Y; Yang T; Tang X; Chen F; Wang S
    Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EasyGuide Plasmids Support in Vivo Assembly of gRNAs for CRISPR/Cas9 Applications in
    Jacobus AP; Barreto JA; de Bem LS; Menegon YA; Fier Í; Bueno JGR; Dos Santos LV; Gross J
    ACS Synth Biol; 2022 Nov; 11(11):3886-3891. PubMed ID: 36257021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
    Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
    Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.
    Smith LM; Ladner JT; Hodara VL; Parodi LM; Harris RA; Callery JE; Lai Z; Zou Y; Raveedran M; Rogers J; Giavedoni LD
    J Virol; 2021 Nov; 95(23):e0088221. PubMed ID: 34549979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing.
    Xie K; Yang Y
    Methods Mol Biol; 2019; 1917():63-73. PubMed ID: 30610628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frankenstein Cas9: engineering improved gene editing systems.
    Vos PD; Filipovska A; Rackham O
    Biochem Soc Trans; 2022 Oct; 50(5):1505-1516. PubMed ID: 36305591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step genome editing of porcine zygotes through the electroporation of a CRISPR/Cas9 system with two guide RNAs.
    Hirata M; Wittayarat M; Tanihara F; Sato Y; Namula Z; Le QA; Lin Q; Takebayashi K; Otoi T
    In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):614-621. PubMed ID: 32978715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.
    Brown W; Zhou W; Deiters A
    Chembiochem; 2021 Jan; 22(1):63-72. PubMed ID: 32833316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
    Neldeborg S; Lin L; Stougaard M; Luo Y
    Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
    Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
    Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cas9-mediated DNA cleavage guided by enzymatically prepared 4'-thio-modified RNA.
    Saito-Tarashima N; Ueno M; Murai A; Matsuo A; Minakawa N
    Org Biomol Chem; 2022 Jul; 20(26):5245-5248. PubMed ID: 35726625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The length of guide RNA and target DNA heteroduplex effects on CRISPR/Cas9 mediated genome editing efficiency in porcine cells.
    Lv J; Wu S; Wei R; Li Y; Jin J; Mu Y; Zhang Y; Kong Q; Weng X; Liu Z
    J Vet Sci; 2019 May; 20(3):e23. PubMed ID: 31161741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.